|
InfoMedSearch
Medical - Health Information and Search Services
| |
Prostate Cancer
Treatment is updated with the most recent articles listed on top. REVIEW our Selected Prostate Cancer Articles in 2007. Stay informed and updated! Also review Related Articles:Prostatitis and BPH.
InfoMedSearch
Monthly Newsletter AlertsSave Time. Stay updated monthly. Read our selected articles on a monthly basis. Sign up for our monthly Newsletter alerts - view only our last month's selections. Prostate Cancer
NHS - Prostate cancer “Diagnosing prostate cancer Prostate-specific antigen (PSA) testing The main test for prostate cancer is the PSA (prostate-specific antigen) test, which looks for raised levels of PSA in the blood. Prostate cancer increases the production of PSA, so the test may be able to detect prostate cancer in its early stages. However, the test is problematic: • Up to 20% of men who do have prostate cancer will not have a raised PSA level; • Over 65% of men with a raised PSA level will not have cancer. PSA levels tend to rise in all men as they get older. Digital rectal examination The next step to confirming a diagnosis of prostate cancer is a digital rectal examination (DRE). This can be done by your GP. During a DRE, your GP will insert a finger into your rectum (back passage). The rectum is close to your prostate gland, so your GP is able to check to see if the surface of the gland has changed. This will feel a little uncomfortable but it should not cause you pain. Prostate cancer can cause the gland to become hard and bumpy. However, in some cases, the cancer causes no changes to the gland and a DRE may not be able to detect the cancer. DRE is also useful in ruling out benign prostatic hyperplasia, as this causes the gland to feel firm and smooth. Biopsy Your GP will assess the risk of you possibly having prostate cancer based on a number of factors, including your PSA levels, the results of your DRE and associated risk factors such as age, family history and ethnic group. If it is felt that the risk is significant you will be referred to a hospital to discuss the options of further tests. The most commonly used test is known as a transrectal ultrasound-guided biopsy (TRUS). During a TRUS biopsy, an ultrasound scanner (a machine that uses sound waves to build up a picture of the inside of your body) is used to study your prostate. This also allows the doctor to guide a needle through your rectum which is then used to take small samples of tissue from your prostate (biopsy). The procedure can be uncomfortable and sometimes painful. You may be given a local anaesthetic to minimize any discomfort. The biopsy may also cause complications such as bleeding and infection. Although it is much more reliable than a PSA test, a biopsy may miss up to 20% of cancers. Therefore, you may need to undergo another biopsy if your symptoms persist, or your PSA level continues to rise. Gleason score The samples of tissue from the biopsy are then studied in a laboratory. If cancerous cells are found, they can be studied further to see how quickly the cancer will spread. This is done by giving the samples a grade, known as a Gleason score. The lower the score, the less likely the cancer will spread. • a Gleason score of 6 or less means the cancer is unlikely to spread, • a Gleason score of 7 means that there is a moderate chance of the cancer spreading, and • a Gleason score of 8 or above means that there is a significant chance that the cancer will spread. Further testing If it is felt that there is a significant chance that the cancer has spread from your prostate to other parts of the body, further tests may be recommended. Two tests that are commonly used are: • A magnetic resonance imaging (MRI ) scan - which uses magnetic waves to build up a detailed picture of the inside of your body. A MRI scan can tell if the cancer has spread beyond the prostate to the surrounding tissue. • An isotope bone scan - this test uses radiation to detect any abnormalities in your bones. An isotope bone scan can tell if the cancer has spread to your bones. “ NIH - Prostate cancer (Medical Encyclopedia) "The cause of prostate cancer is unknown, although some studies have shown a relationship between high dietary fat intake and increased testosterone levels. … Prostate cancer is the third most common cause of death from cancer in men of all ages and is the most common cause of death from cancer in men over 75 years old. Prostate cancer is rarely found in men younger than 40. … Men at higher risk include black men older than 60, farmers, tire plant workers, painters, and men exposed to cadmium. The lowest incidence occurs in Japanese men and vegetarians. Prostate cancers are classified or staged based on their aggressiveness and how different they are from the surrounding prostate tissue. There are several different ways to stage tumors, a common one being the A-B-C-D staging system, also known as the Whitmore-Jewett system: A: Tumor is not palpable (not felt on physical examination), and is usually detected by accident after prostate surgery done for other reasons. B: Tumor is confined to the prostate and usually detected by physical examination or PSA testing. C: Tumor extends beyond the prostate capsule without spread to lymph nodes. D: Cancer has spread (metastasized) to regional lymph nodes or other parts of the body (bone and lungs, for example) Highlighted Articles
Doctors Urged Not to Screen Elderly Men for Prostate Cancer (2008) “In a move that could lead to significant changes in medical care for older men, a national task force on Monday recommended that doctors stop screening men ages 75 and older for prostate cancer because the search for the disease in this group is causing more harm than good.” Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort (Cancer Epidemiology Biomarkers & Prevention 2007) "Conclusion: Obesity increases the risk of more aggressive prostate cancer and may decrease either the occurrence or the likelihood of diagnosis of less-aggressive tumors. Men who lose weight may reduce their risk of prostate cancer." Meat Consumption among Black and White Men and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort (Cancer Epidemiol Biomarkers Prev 2006) "No measure of meat consumption was associated with risk of prostate cancer among White men. Among Black men, total red meat intake (processed plus unprocessed red meat) was associated with higher risk of prostate cancer … this increase in risk was mainly due to risk associated with consumption of cooked processed meats (sausages, bacon, and hot dogs … This study suggests that high consumption of cooked processed meats may contribute to prostate cancer risk among Black men in the United States." Highlighted Internet SitesContinue your InfoMedSearch research with our previous InfoMedLinks. Start with InfoMedLinks 2007. Searching for more specific information related to your condition? InfoMedSearch researchers can search and provide you with a custom report. We can also keep you updated. Great Price! Check out our Search Services page. Use our experience to find the important medical information you need. Help protect you and your family's health.
Custom Search
|
Prostate CancerGeneral InformationNEWS:Elevated C-Reactive Protein Predicts Poor Outcome in Prostate Cancer High Serum Calcium Linked to Higher Risk for Fatal Prostate Cancer “Serum calcium levels are not associated with incident prostate cancer. • The risk for fatal prostate cancer is increased more than 2.5-fold in men with the highest tertile of serum calcium vs the lowest tertile of serum calcium. “ Long-Term Prediction Of Prostate Cancer Prostate Cancer Prognosis Worse in Obese Men “Prostate cancer diagnosis tends to be delayed and complete surgical resection more difficult in obese men than in lean men, according to two reports in BJU International, published online on August 8. The primary reason for the delay in diagnosis, and consequently poorer outcome, Dr. Stephen J. Freedland and colleagues suggest, is that "prostate-specific antigen (PSA)-based screening is biased against obese men," due to lower PSA levels caused by hemodilution from a larger plasma volume.“ Researchers investigate links between prostate, cadmium, zinc “Cadmium exposure is a known risk factor for prostate cancer, and a new University of Rochester study suggests that zinc may offer protection against cadmium. … Cadmium exposure occurs mostly through smoking and diet, the latter as a result of fertilizer-soaked soil used for growing crops. Cadmium is also a byproduct of the industrial process used for making fungicides, batteries, pigments and coatings that protect metals from corrosion. Workers in those areas are at risk for much higher exposures. When ingested or inhaled, cadmium collects in the liver, kidneys and prostate.” Vitamin D May Not Decrease Risk for Prostate Cancer “ "The absence of a link between vitamin D and prostate cancer risk, even if ultimately confirmed, should not be misinterpreted as evidence against other well-documented health benefits of vitamin D," Drs. Mucci and Spiegelman write. "The weight of evidence does suggest that increased vitamin D levels — from diet, supplementation, or sun exposure — are likely to have a modest beneficial effect on the overall burden of chronic disease in the United States and other epidemiologically similar countries." “ ARTICLES:JAMA patient page. Prostate cancer. JOURNAL ARTICLES:A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality. (Am J Clin Nutr. 2008) [Antioxidant power and cellular damage in prostate cancer] (Arch Esp Urol. 2008 ) Can Physicians Accurately Predict Survival Time in Patients with Metastatic Cancer? Analysis of RTOG 97-14. (J Palliat Med. 2008) Effect of diet and exercise intervention on the growth of prostate epithelial cells. (Prostate Cancer Prostatic Dis. 2008) Experiences of symptoms in men with hormone refractory prostate cancer and skeletal metastases. (Eur J Oncol Nurs. 2008) Fish intake and the risk of fatal prostate cancer: findings from a cohort study in Japan. (Public Health Nutr. 2008) “CONCLUSIONS: These results support the hypothesis that a high intake of fish may decrease the risk of prostate cancer death.” Positive Nonsentinel Node Status Predicts Mortality in Patients with Cutaneous Melanoma. (Ann Surg Oncol. 2008) Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey (Cancer Epidemiology Biomarkers & Prevention 2008) “These results support the hypothesis that high serum calcium or a factor strongly associated with it (e.g., high serum parathyroid hormone) increases the risk for fatal prostate cancer. Our finding of a >2.5-fold increased risk for men in the highest tertile of serum calcium is comparable in magnitude with the risk associated with family history and could add significantly to our ability to identify men at increased risk for fatal prostate cancer.” Serum selenium level and prostate cancer: a case-control study. (Nutr Cancer. 2008) Serum Vitamin D Concentration and Prostate Cancer Risk: A Nested Case-Control Study. (J Natl Cancer Inst. 2008) The face of high risk prostate cancer. (World J Urol. 2008) What is low-risk prostate cancer and what is its natural history? (World J Urol. 2008) |
| Privacy Policy | Disclaimer | Research | Suggestions | Subscriptions | Contact Us | |
© 2004-2008, InfoMedSearch, LLC. All rights reserved. | Site design: mqstudio